1
|
Reiner J, Chung Y, Misha SH, Lehner C, Moehle C, Poulos D, Monir S, Charde KJ, Macha P, Kranz L, Thorvaldson I, Thorgrimsson B, Keith D, Hsueh YL, Rahman R, Gorman SK, Keizer JG, Simmons MY. High-fidelity initialization and control of electron and nuclear spins in a four-qubit register. Nat Nanotechnol 2024:10.1038/s41565-023-01596-9. [PMID: 38326467 DOI: 10.1038/s41565-023-01596-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 12/20/2023] [Indexed: 02/09/2024]
Abstract
Single electron spins bound to multi-phosphorus nuclear spin registers in silicon have demonstrated fast (0.8 ns) two-qubit [Formula: see text] gates and long spin relaxation times (~30 s). In these spin registers, when the donors are ionized, the nuclear spins remain weakly coupled to their environment, allowing exceptionally long coherence times. When the electron is present, the hyperfine interaction allows coupling of the spin and charge degrees of freedom for fast qubit operation and control. Here we demonstrate the use of the hyperfine interaction to enact electric dipole spin resonance to realize high-fidelity ([Formula: see text]%) initialization of all the nuclear spins within a four-qubit nuclear spin register. By controllably initializing the nuclear spins to [Formula: see text], we achieve single-electron qubit gate fidelities of F = 99.78 ± 0.07% (Clifford gate fidelities of 99.58 ± 0.14%), above the fault-tolerant threshold for the surface code with a coherence time of [Formula: see text].
Collapse
Affiliation(s)
- J Reiner
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - Y Chung
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - S H Misha
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - C Lehner
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - C Moehle
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - D Poulos
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - S Monir
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
- School of Physics, University of New South Wales, Sydney, New South Wales, Australia
| | - K J Charde
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - P Macha
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - L Kranz
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - I Thorvaldson
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - B Thorgrimsson
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - D Keith
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - Y L Hsueh
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
- School of Physics, University of New South Wales, Sydney, New South Wales, Australia
| | - R Rahman
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
- School of Physics, University of New South Wales, Sydney, New South Wales, Australia
| | - S K Gorman
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - J G Keizer
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia
| | - M Y Simmons
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, University of New South Wales, Sydney, New South Wales, Australia.
- Silicon Quantum Computing Pty Ltd., University of New South Wales, Sydney, New South Wales, Australia.
| |
Collapse
|
2
|
Schäffer AA, Chung Y, Kammula AV, Ruppin E, Lee JS. A systematic analysis of the landscape of synthetic lethality-driven precision oncology. Med 2024; 5:73-89.e9. [PMID: 38218178 DOI: 10.1016/j.medj.2023.12.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 09/10/2023] [Accepted: 12/13/2023] [Indexed: 01/15/2024]
Abstract
BACKGROUND Synthetic lethality (SL) denotes a genetic interaction between two genes whose co-inactivation is detrimental to cells. Because more than 25 years have passed since SL was proposed as a promising way to selectively target cancer vulnerabilities, it is timely to comprehensively assess its impact so far and discuss its future. METHODS We systematically analyzed the literature and clinical trial data from the PubMed and Trialtrove databases to portray the preclinical and clinical landscape of SL oncology. FINDINGS We identified 235 preclinically validated SL pairs and found 1,207 pertinent clinical trials, and the number keeps increasing over time. About one-third of these SL clinical trials go beyond the typically studied DNA damage response (DDR) pathway, testifying to the recently broadening scope of SL applications in clinical oncology. We find that SL oncology trials have a greater success rate than non-SL-based trials. However, about 75% of the preclinically validated SL interactions have not yet been tested in clinical trials. CONCLUSIONS Dissecting the recent efforts harnessing SL to identify predictive biomarkers, novel therapeutic targets, and effective combination therapy, our systematic analysis reinforces the hope that SL may serve as a key driver of precision oncology going forward. FUNDING Funded by the Samsung Research Funding & Incubation Center of Samsung Electronics, the Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Republic of Korea government (MSIT), the Kwanjeong Educational Foundation, the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), and Center for Cancer Research (CCR).
Collapse
Affiliation(s)
- Alejandro A Schäffer
- Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
| | - Youngmin Chung
- Department of Artificial Intelligence, Sungkyunkwan University, Suwon 16419, Republic of Korea
| | - Ashwin V Kammula
- Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
| | - Eytan Ruppin
- Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
| | - Joo Sang Lee
- Department of Artificial Intelligence, Sungkyunkwan University, Suwon 16419, Republic of Korea; Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea; Department of Digital Health & Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Samsung Medical Center, Sungkyunkwan University, Seoul 06351, Republic of Korea.
| |
Collapse
|
3
|
Naqash AR, McCallen JD, Mi E, Iivanainen S, Marie MA, Gramenitskaya D, Clark J, Koivunen JP, Macherla S, Jonnalagadda S, Polsani S, Jiwani RA, Hafiz M, Muzaffar M, Brunetti L, Stroud CRG, Walker PR, Wang K, Chung Y, Ruppin E, Lee SH, Yang LV, Pinato DJ, Lee JS, Cortellini A. Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer 2023; 11:e007310. [PMID: 37852738 PMCID: PMC10603340 DOI: 10.1136/jitc-2023-007310] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/13/2023] [Indexed: 10/20/2023] Open
Abstract
BACKGROUND Systemic immune activation, hallmarked by C-reactive protein (CRP) and interleukin-6 (IL-6), can modulate antitumor immune responses. In this study, we evaluated the role of IL-6 and CRP in the stratification of patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). We also interrogated the underlying immunosuppressive mechanisms driven by the IL-6/CRP axis. METHODS In cohort A (n=308), we estimated the association of baseline CRP with objective response rate (ORR), progression-free survival (PFS), and overall survival (OS) in patients with NSCLC treated with ICIs alone or with chemo-immunotherapy (Chemo-ICI). Baseline tumor bulk RNA sequencing (RNA-seq) of lung adenocarcinomas (LUADs) treated with pembrolizumab (cohort B, n=59) was used to evaluate differential expression of purine metabolism, as well as correlate IL-6 expression with PFS. CODEFACS approach was applied to deconvolve cohort B to characterize the tumor microenvironment by reconstructing the cell-type-specific transcriptome from bulk expression. Using the LUAD cohort from The Cancer Genome Atlas (TCGA) we explored the correlation between IL-6 expression and adenosine gene signatures. In a third cohort (cohort C, n=18), plasma concentrations of CRP, adenosine 2a receptor (A2aR), and IL-6 were measured using ELISA. RESULTS In cohort A, 67.2% of patients had a baseline CRP≥10 mg/L (CRP-H). Patients with CRP-H achieved shorter OS (8.6 vs 14.8 months; p=0.006), shorter PFS (3.3 vs 6.6 months; p=0.013), and lower ORR (24.7% vs 46.3%; p=0.015). After adjusting for relevant clinical variables, CRP-H was confirmed as an independent predictor of increased risk of death (HR 1.51, 95% CI: 1.09 to 2.11) and lower probability of achieving disease response (OR 0.34, 95% CI: 0.13 to 0.89). In cohort B, RNA-seq analysis demonstrated higher IL-6 expression on tumor cells of non-responders, along with a shorter PFS (p<0.05) and enrichment of the purinergic pathway. Within the TCGA LUAD cohort, tumor IL-6 expression strongly correlated with the adenosine signature (R=0.65; p<2.2e-16). Plasma analysis in cohort C demonstrated that CRP-H patients had a greater median baseline level of A2aR (6.0 ng/mL vs 1.3 ng/mL; p=0.01). CONCLUSIONS This study demonstrates CRP as a readily available blood-based prognostic biomarker in ICI-treated NSCLC. Additionally, we elucidate a potential link of the CRP/IL-6 axis with the immunosuppressive adenosine signature pathway that could drive inferior outcomes to ICIs in NSCLC and also offer novel therapeutic avenues.
Collapse
Affiliation(s)
- Abdul Rafeh Naqash
- Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - Justin D McCallen
- Department of Internal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- Brody School of Medicine, East Carolina University, Greenville, NC, USA
| | - Emma Mi
- Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK
| | - Sanna Iivanainen
- Oncology and Radiation Department, Oulu University Hospital, University of Oulu, MRC Oulu, Oulu, Finland
| | - Mona A Marie
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - Daria Gramenitskaya
- Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK
| | - James Clark
- Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK
| | - Jussi Pekka Koivunen
- Oncology and Radiation Department, Oulu University Hospital, University of Oulu, MRC Oulu, Oulu, Finland
| | - Shravanti Macherla
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - Sweta Jonnalagadda
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - Shanker Polsani
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - Rahim Ali Jiwani
- Department of Internal Medicine, East Carolina University, Greenville, NC, USA
| | - Maida Hafiz
- Division of Pulmonary Critical Care, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
- Division of Pulmonary and Critical Care, East Carolina University, Greenville, NC, USA
| | - Mahvish Muzaffar
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - Leonardo Brunetti
- Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma, Italy, Italy
| | | | - Paul R Walker
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
- Circulogene, Birmingham, Alabama, USA
| | - Kun Wang
- Cancer Data Science Lab, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA
| | - Youngmin Chung
- Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Reuplic of Korea
| | - Eytan Ruppin
- Cancer Data Science Lab, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA
| | - Se-Hoon Lee
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center School of Medicine, Sungkyunkwan University, Seoul, Republic of Korea
- Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea
| | - Li V Yang
- Hematology / Oncology Division, East Carolina University, Greenville, South Carolina, USA
| | - David J Pinato
- Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK
- Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy
| | - Joo Sang Lee
- Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Reuplic of Korea
- Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea
- Department of Digital Health, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea
| | - Alessio Cortellini
- Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK
- Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma, Italy, Italy
| |
Collapse
|
4
|
Ruschel VC, Stolf SC, da Luz Baratieri C, Chung Y, Boushell LW, Baratieri LN, Walter R. Five-year Clinical Evaluation of Universal Adhesives in Noncarious Cervical Lesions. Oper Dent 2023:493223. [PMID: 37226698 DOI: 10.2341/21-132-c] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/27/2022] [Indexed: 05/26/2023]
Abstract
OBJECTIVES To compare the clinical performance of mildly acidic universal adhesives Scotchbond Universal (SU, 3M Oral Care, St Paul, MN, USA) and Prime & Bond Elect (PBE, Dentsply Sirona, Charlotte, NC, USA) in the restoration of noncarious cervical lesions (NCCLs). METHODS AND MATERIALS A total of 63 patients in need of 203 NCCL restorations participated in this randomized controlled clinical trial. Notch-shaped lesions were restored with Kalore (GC Corporation, Tokyo, Japan) after application of either SU or PBE, following the etch-and-rinse (ER) or self-etch (SE) techniques. Subjects were followed up for 60 months. The focus of the statistical analyses was on the change of outcome over time as assessed by the Modified USPHS rating system (ie, Alfa vs Bravo + Charlie outcomes). Logistic regression was performed for each outcome separately with compound symmetric variance-covariance structure assumed to consider a correlation of restorations within subjects. All analyses were conducted using SAS 9.4 (SAS, Cary, NC, USA). RESULTS One-hundred twenty-nine teeth in 35 subjects were assessed at the 60-month follow-up. In addition, three restorations that failed prior to the 60-month evaluation, two of which were in subjects who did not present for the 60-month follow-up, were included in the statistical analysis. In total, two restorations in the SU_ER group and three restorations in the PBE_SE group failed the retention category. Statistically significant differences were obtained for the comparison of restorations in the PBE_SE and PBE_ER groups, where the former was 58% less likely to maintain a score of Alfa for marginal discoloration than the latter. CONCLUSIONS SU and PBE demonstrated acceptable clinical performance at 60 months with regard to restoration retention. Phosphoric-acid etching of the NCCLs prior to adhesive application significantly improved the performance of PBE in regard to marginal discoloration.
Collapse
Affiliation(s)
- V C Ruschel
- Vanessa Carla Ruschel, DDS, MS, PhD, Federal University of Santa Catarina, Florianópolis, SC, Brazil
| | - S C Stolf
- Sheila Cristina Stolf, DDS, MS, PhD, Federal University of Santa Catarina, Florianópolis, SC, Brazil
| | - C da Luz Baratieri
- Carolina da Luz Baratieri, DDS, MS, PhD, Federal University of Santa Catarina, Florianópolis, SC, Brazil
| | - Y Chung
- Yunro Chung, PhD, College of Health Solutions, Arizona State University, Phoenix, AZ, USA; Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
| | - L W Boushell
- Lee Warren Boushell, DDS, MS, East Carolina State University, Greenville, NC, USA
| | - L N Baratieri
- Luiz Narciso Baratieri, DDS, MS, PhD, Federal University of Santa Catarina, Florianópolis, SC, Brazil
| | - R Walter
- *Ricardo Walter, DDS, MS, University of North Carolina at Chapel Hill School of Dentistry, Chapel Hill, NC, USA
| |
Collapse
|
5
|
Lee JS, Chung Y, Kammula AV, Schaffer AA, Ruppin E. Abstract 946: A silver jubilee for synthetic lethality in cancer treatment: where do we stand. Cancer Res 2023. [DOI: 10.1158/1538-7445.am2023-946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2023]
Abstract
Abstract
Background: Synthetic lethality (SL) denotes a genetic interaction between two genes whose co-inactivation is detrimental to cells. Since the seminal paper of Hartwell and colleagues has raised the possibility that SL can be used to devise highly selective cancer treatments, it has been one of the promising approaches for precision oncology and drug discovery. Many different avenues have so far been explored to bring this idea to the clinic. As 25 years have passed by now, we take stock and systematically and comprehensively chart the landscape of SL-based preclinical research and clinical trials.
Approach and Key Findings: We systematically mined both public and commercial databases to curate the preclinical and clinical landscape of the SL-based oncology studies. Our analysis shows that the number of SL oncology studies is rapidly growing since the first identification of the well-known BRCA-PARP synthetic lethality axis. Importantly, we find that the success rate of SL oncology trials is significantly higher than non-SL-based trials. While more than 70% of SL-oncology trials involve genes in the most-studied DNA damage response (DDR) pathways, the fraction of SL trials involving non-DDR pathways keeps growing since 2009. We further charted the landscape of SL triplets, which is a promising future higher-order extension of the conventional pairwise SL interactions. We find that only about 8% of preclinically validated SL triplets were clinically tested in trials, providing new opportunities for more refined clinical trial design. Our analysis suggests that emerging opportunities in SL oncology may arise from metabolic and paralogous interactions, disease-agnostic biomarkers, context-specific combinations against treatment resistance, artificial intelligence and data science approaches, and multi-omics patient stratification signatures.
Significance: Taken together, our findings testify that a considerable potential benefits of SL based approaches are yet untapped, reinforcing the belief that the synthetic lethality approach may serve as a key driver of precision oncology going forward.
Citation Format: Joo Sang Lee, Youngmin Chung, Ashwin V. Kammula, Alejandro A. Schaffer, Eytan Ruppin. A silver jubilee for synthetic lethality in cancer treatment: where do we stand [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 946.
Collapse
Affiliation(s)
- Joo Sang Lee
- 1Sungkyunkwan University, Suwon, Republic of Korea
| | | | | | | | | |
Collapse
|
6
|
Noronha A, Belugali Nataraj N, Lee JS, Zhitomirsky B, Oren Y, Oster S, Lindzen M, Mukherjee S, Will R, Ghosh S, Simoni-Nieves A, Verma A, Chatterjee R, Borgoni S, Robinson W, Sinha S, Brandis A, Kerr DL, Wu W, Sekar A, Giri S, Chung Y, Drago-Garcia D, Danysh BP, Lauriola M, Fiorentino M, Ardizzoni A, Oren M, Blakely CM, Ezike J, Wiemann S, Parida L, Bivona TG, Aqeilan RI, Brugge JS, Regev A, Getz G, Ruppin E, Yarden Y. AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer. Cancer Discov 2022; 12:2666-2683. [PMID: 35895872 PMCID: PMC9627128 DOI: 10.1158/2159-8290.cd-22-0111] [Citation(s) in RCA: 31] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Revised: 05/10/2022] [Accepted: 07/25/2022] [Indexed: 02/06/2023]
Abstract
Anticancer therapies have been limited by the emergence of mutations and other adaptations. In bacteria, antibiotics activate the SOS response, which mobilizes error-prone factors that allow for continuous replication at the cost of mutagenesis. We investigated whether the treatment of lung cancer with EGFR inhibitors (EGFRi) similarly engages hypermutators. In cycling drug-tolerant persister (DTP) cells and in EGFRi-treated patients presenting residual disease, we observed upregulation of GAS6, whereas ablation of GAS6's receptor, AXL, eradicated resistance. Reciprocally, AXL overexpression enhanced DTP survival and accelerated the emergence of T790M, an EGFR mutation typical to resistant cells. Mechanistically, AXL induces low-fidelity DNA polymerases and activates their organizer, RAD18, by promoting neddylation. Metabolomics uncovered another hypermutator, AXL-driven activation of MYC, and increased purine synthesis that is unbalanced by pyrimidines. Aligning anti-AXL combination treatments with the transition from DTPs to resistant cells cured patient-derived xenografts. Hence, similar to bacteria, tumors tolerate therapy by engaging pharmacologically targetable endogenous mutators. SIGNIFICANCE EGFR-mutant lung cancers treated with kinase inhibitors often evolve resistance due to secondary mutations. We report that in similarity to the bacterial SOS response stimulated by antibiotics, endogenous mutators are activated in drug-treated cells, and this heralds tolerance. Blocking the process prevented resistance in xenograft models, which offers new treatment strategies. This article is highlighted in the In This Issue feature, p. 2483.
Collapse
Affiliation(s)
- Ashish Noronha
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | | | - Joo Sang Lee
- Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland.,Next-Gen Medicine Lab, School of Medicine and Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Republic of Korea
| | | | - Yaara Oren
- Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.,Department of Cell Biology, Harvard Medical School, Boston, Massachusetts
| | - Sara Oster
- Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel
| | - Moshit Lindzen
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Saptaparna Mukherjee
- Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
| | - Rainer Will
- Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Soma Ghosh
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Arturo Simoni-Nieves
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Aakanksha Verma
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Rishita Chatterjee
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Simone Borgoni
- Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | | | - Sanju Sinha
- Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland
| | - Alexander Brandis
- Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel
| | - D. Lucas Kerr
- Department of Medicine, University of California, San Francisco, California
| | - Wei Wu
- Department of Medicine, University of California, San Francisco, California
| | - Arunachalam Sekar
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Suvendu Giri
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Youngmin Chung
- Next-Gen Medicine Lab, School of Medicine and Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Republic of Korea
| | - Diana Drago-Garcia
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
| | - Brian P. Danysh
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts
| | - Mattia Lauriola
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
| | - Michelangelo Fiorentino
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
| | - Andrea Ardizzoni
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.,Medical Oncology IRCCS Azienda Ospedaliero, University of Bologna, Bologna, Italy
| | - Moshe Oren
- Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
| | - Collin M. Blakely
- Department of Medicine, University of California, San Francisco, California.,Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California
| | - Jideofor Ezike
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts.,Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts
| | - Stefan Wiemann
- Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Laxmi Parida
- Thomas J. Watson Research Center, IBM Research, Yorktown Heights, New York
| | - Trever G. Bivona
- Department of Medicine, University of California, San Francisco, California.,Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.,Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California
| | - Rami I. Aqeilan
- Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel
| | - Joan S. Brugge
- Department of Cell Biology, Harvard Medical School, Boston, Massachusetts
| | - Aviv Regev
- Genentech Inc., South San Francisco, California
| | - Gad Getz
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts.,Cancer Center and Department of Pathology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts
| | - Eytan Ruppin
- Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland
| | - Yosef Yarden
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.,Corresponding Author: Yosef Yarden, Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. Phone: 972-8-934-3974; Fax: 972-8-934-2488; E-mail:
| |
Collapse
|
7
|
Carstens D, Smith J, Chung Y, Pan S, Barlows T, Nepal B, Barron J. REDUCTIONS IN EXACERBATIONS OF SEVERE ASTHMA PATIENTS TREATED WITH BENRALIZUMAB – ZEPHYR 3. Ann Allergy Asthma Immunol 2022. [DOI: 10.1016/j.anai.2022.08.615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
8
|
Chung Y, Carr T, Ambrose C, Lindsley A, Collacott H, Schulz A, Desai P, Rane P, Williams M. PATIENT AND CLINICIAN PREFERENCES WITH BIOLOGIC TREATMENTS FOR SEVERE ASTHMA: A DISCRETE CHOICE EXPERIMENT. Ann Allergy Asthma Immunol 2022. [DOI: 10.1016/j.anai.2022.08.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Chung Y, Tsoi L, White BEP, Zeng C, Billi A, Gudjonsson J. 482 Differences in chromatin accessibility in male vs female keratinocytes using ATAC-seq. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
10
|
Melo P, Eapen A, Chung Y, Jeve Y, Price MJ, Sunkara SK, Macklon NS, Bhattacharya S, Khalaf Y, Tobias A, Broekmans F, Khairy M, Gallos I, Coomarasamy A. O-009 Controlled ovarian stimulation (COS) protocols for assisted reproduction: a Cochrane systematic review and network meta-analysis. Hum Reprod 2022. [DOI: 10.1093/humrep/deac104.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
What is the relative effectiveness and safety of existing COS protocols for women undergoing assisted reproductive technology (ART) treatment?
Summary answer
There was no difference in live birth between all protocols, but short antagonist protocols may reduce ovarian hyperstimulation syndrome in women with predicted normal/high response.
What is known already
Controlled ovarian stimulation is an essential step in most ART cycles. It involves the administration of exogenous gonadotrophins to induce multifollicular growth, usually in addition to drugs that prevent untimely ovulation by suppressing the pituitary gland. Different treatment combinations may be used in COS. These vary according to the type of drugs administered for pituitary suppression (e.g., gonadotrophin-releasing hormone [GnRH] agonists, antagonists) and ovarian stimulation (e.g., urinary or recombinant gonadotrophins). Drug dosages, timing and routes of administration also vary between different regimens. However, there is no consensus on how the existing COS protocols rank according to their effectiveness and safety.
Study design, size, duration
We searched the following databases to November 2021: MEDLINE, EMBASE, CINAHL, CENTRAL and ClinicalTrials.gov. We included randomised controlled trials (RCTs) comparing at least two COS protocols using GnRH agonists or antagonists for pituitary suppression; and human menopausal gonadotrophin (hMG), urinary or recombinant follicle-stimulating hormone (u/rFSH), with or without luteinising hormone (LH) for ovarian stimulation. The primary outcomes were the rates of live birth (LBR) and ovarian hyperstimulation syndrome (OHSS) per participant after one stimulation cycle.
Participants/materials, setting, methods
Two reviewers independently selected studies and extracted data. We conducted pairwise and network meta-analyses (NMA) according to participants’ predicted response to COS (normal, high and low). Using the Cochrane-RoB-1 tool, we restricted our primary analyses to RCTs at low risk of selection and other biases. We presented effect estimates as risk ratio (RR) with 95% confidence interval (CI) and considered I2>50% as representing substantial heterogeneity. For each outcome, we generated ranking plots comparing different interventions.
Main results and the role of chance
In total, our searches identified 9464 studies. The primary analysis included 68 RCTs assessing 17861 women and 34 different COS protocols. The evidence showed that in women with predicted normal or high response, the use of short GnRH antagonist protocols may result in little to no difference in LBR (RR 0.98, 95% CI 0.85 to 1.13; 6 studies; 2063 women; I2 = 0%; low-certainty evidence) and a reduction in OHSS (RR 0.88, 95% CI 0.78 to 0.99; 7 studies; 2246 women; I2 = 0%; low-certainty evidence) compared with long GnRH agonist protocols. The rankogram comparing different COS protocols showed a probability of 98% that short GnRH antagonist regimens are the best treatment to prevent OHSS. Sensitivity analyses including all studies showed that in women with predicted normal response undergoing long GnRH agonist cycles for pituitary suppression, the use of rFSH for ovarian stimulation may result in decreased fresh-cycle LBR compared to hMG (RR 0.80, 95% CI 0.68 to 0.95; 7 studies; 1575 women; I2 = 1%; low-certainty evidence). For the remaining interventions (e.g., agonist flare or progestogens for pituitary suppression, in combination with various gonadotrophin regimens) the evidence was uncertain of an effect or insufficient for quantitative synthesis.
Limitations, reasons for caution
The high number of interventions resulted in disconnected networks, limiting our ability to perform NMA for some comparisons. The certainty of the evidence was limited by serious risk of bias. Finally, the lack of data on cumulative LBR and differences in oocyte yield made comparisons between FSH preparations potentially unbalanced.
Wider implications of the findings
Our findings suggest that the use of short GnRH antagonist protocols may result in reduced OHSS rates in women with predicted normal or high ovarian response without compromising live birth rates. There is a paucity of high-quality RCTs comparing different gonadotrophin preparations (e.g., hMG versus rFSH) for COS.
Trial registration number
N/A
Collapse
Affiliation(s)
- P Melo
- Tommy's National Centre for Miscarriage Research, University of Birmingham , Birmingham, United Kingdom
| | - A Eapen
- REI Division - Carver College of Medicine, University of Iowa Hospital and Clinics , Iowa, U.S.A
| | - Y Chung
- Tommy's National Centre for Miscarriage Research, University of Birmingham , Birmingham, United Kingdom
| | - Y Jeve
- Department of Obstetrics and Gynaecology, Birmingham Women's Hospital , Birmingham, United Kingdom
| | - M J Price
- Institute of Applied Health Research, University of Birmingham , Birmingham, United Kingdom
| | - S K Sunkara
- Division of Women's Health - Faculty of Life Sciences and Medicine, King's College London , London, United Kingdom
| | - N S Macklon
- London Women's Clinic, London Women's Clinic , London, United Kingdom
| | - S Bhattacharya
- School of Medicine- Medical Sciences and Nutrition, University of Aberdeen , Aberdeen, United Kingdom
| | - Y Khalaf
- Assisted Conception Unit and Centre for Preimplantation Genetic Diagnosis, Guy's and St Thomas' Hospital and King's College London, London , United Kingdom
| | - A Tobias
- Tommy's National Centre for Miscarriage Research, University of Birmingham , Birmingham, United Kingdom
| | - F Broekmans
- Center for Reproductive Medicine, University Medical Center Utrecht , Utrecht, The Netherlands
| | - M Khairy
- CARE Fertility Birmingham, CARE Fertility , Birmingham, United Kingdom
| | - I Gallos
- Tommy's National Centre for Miscarriage Research, University of Birmingham , Birmingham, United Kingdom
| | - A Coomarasamy
- Tommy's National Centre for Miscarriage Research, University of Birmingham , Birmingham, United Kingdom
| |
Collapse
|
11
|
Kiczynski M, Gorman SK, Geng H, Donnelly MB, Chung Y, He Y, Keizer JG, Simmons MY. Engineering topological states in atom-based semiconductor quantum dots. Nature 2022; 606:694-699. [PMID: 35732762 PMCID: PMC9217742 DOI: 10.1038/s41586-022-04706-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Accepted: 03/01/2022] [Indexed: 11/21/2022]
Abstract
The realization of controllable fermionic quantum systems via quantum simulation is instrumental for exploring many of the most intriguing effects in condensed-matter physics1–3. Semiconductor quantum dots are particularly promising for quantum simulation as they can be engineered to achieve strong quantum correlations. However, although simulation of the Fermi–Hubbard model4 and Nagaoka ferromagnetism5 have been reported before, the simplest one-dimensional model of strongly correlated topological matter, the many-body Su–Schrieffer–Heeger (SSH) model6–11, has so far remained elusive—mostly owing to the challenge of precisely engineering long-range interactions between electrons to reproduce the chosen Hamiltonian. Here we show that for precision-placed atoms in silicon with strong Coulomb confinement, we can engineer a minimum of six all-epitaxial in-plane gates to tune the energy levels across a linear array of ten quantum dots to realize both the trivial and the topological phases of the many-body SSH model. The strong on-site energies (about 25 millielectronvolts) and the ability to engineer gates with subnanometre precision in a unique staggered design allow us to tune the ratio between intercell and intracell electron transport to observe clear signatures of a topological phase with two conductance peaks at quarter-filling, compared with the ten conductance peaks of the trivial phase. The demonstration of the SSH model in a fermionic system isomorphic to qubits showcases our highly controllable quantum system and its usefulness for future simulations of strongly interacting electrons. Precision-engineered devices consisting of a linear array of ten quantum dots are used to realize both the trivial and topological phases of the many-body Su–Schrieffer–Heeger model.
Collapse
Affiliation(s)
- M Kiczynski
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia
| | - S K Gorman
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia
| | - H Geng
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia
| | - M B Donnelly
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia
| | - Y Chung
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia
| | - Y He
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Shenzhen Institute for Quantum Science and Engineering, Southern University of Science and Technology, Shenzhen, China
| | - J G Keizer
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia.,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia
| | - M Y Simmons
- Centre of Excellence for Quantum Computation and Communication Technology, School of Physics, UNSW Sydney, Kensington, New South Wales, Australia. .,Silicon Quantum Computing Pty Ltd, UNSW Sydney, Kensington, New South Wales, Australia.
| |
Collapse
|
12
|
Bae Y, Heo J, Chung Y, Shin SY, Lee SW. Effect of total cholesterol level variabilities on cerebrovascular disease. Eur Rev Med Pharmacol Sci 2022; 26:544-557. [PMID: 35113431 DOI: 10.26355/eurrev_202201_27882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE Hyperlipidemia is a risk factor of cerebrovascular disease (CVD). However, the relationship between CVD and cholesterol variability is less clear. This study assesses the relationship between cholesterol change and CVD risk. PATIENTS AND METHODS We reviewed 480,830 people from 20 to 99 years with 2 health check-ups from 2002 to 2015 from the Korean National Health Insurance (KNHI) database. People's baseline and follow-up cholesterol levels were classified into low (<180 mg/dL), moderate (≥180 mg/dL and <240 mg/dL), and high (≥240 mg/dL). Participants were divided into 9 groups (low-to-low, low-to-moderate, low-to-high, moderate-to-low, moderate-to-moderate, moderate-to-high, high-to-low, high-to-moderate, high-to-high). RESULTS Low to high cholesterol level is associated with hemorrhagic stroke (aHR1 = 1.59; 95% CI 1.12-2.28 and aHR2 = 1.56; 95% CI 1.07-2.25). Low to moderate/high cholesterol level is associated with ischemic stroke and occlusion/stenosis (for low to moderate, aHR1 = 1.11; 95% CI 1.04-1.17 and aHR2 = 1.14; 95% CI 1.07-1.21 for ischemic stroke and aHR1 = 1.18; 95% CI 1.07-1.29 and aHR2 = 1.20; 95% CI 1.08-1.32 for occlusion/stenosis, for low to high, aHR1 = 1.42; 95% CI 1.20-1.67 and aHR2 = 1.28; 95% CI 1.08-1.52 for ischemic stroke and aHR1 = 1.86; 95% CI 1.46-2.36 and aHR2= 1.74; 95% CI 1.36-2.23 for occlusion/stenosis). Moderate to high cholesterol level is associated with ischemic stroke and occlusion/stenosis (for ischemic stroke, aHR1 = 1.12; 95% CI 1.05-1.20 and aHR2 = 1.10; 95% CI 1.03-1.17, for occlusion/stenosis, aHR1 = 1.21; 95% CI 1.10-1.33 and aHR2 = 1.19; 95% CI 1.08-1.32). Moderate to low cholesterol level is associated with ischemic and hemorrhagic stroke and occlusion/stenosis (for ischemic, aHR1 = 1.15; 95% CI 1.09-1.21, for hemorrhagic, aHR1 = 1.14; 95% CI 1.01-1.28, for occlusion/stenosis, aHR1 = 1.14; 95% CI 1.05-1.23). High to low cholesterol level is associated with ischemic stroke and occlusion/stenosis (for ischemic stroke, aHR1 = 1.51; 95% CI 1.33-1.71 and aHR2 = 1.20; 95% CI 1.05-1.36, for occlusion/stenosis, aHR1 = 1.50; 95% CI 1.24-1.81). CONCLUSIONS Our study shows that cholesterol changes, especially larger changes, lead to an increase in CVD, which demonstrates that cholesterol variability may increase CVD.
Collapse
Affiliation(s)
- Y Bae
- Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
| | | | | | | | | |
Collapse
|
13
|
Maselli D, Carstens D, Yang D, Mu F, Young J, Cook E, Betts K, Chung Y. P061 BENRALIZUMAB IS EFFECTIVE IN REDUCING ASTHMA EXACERBATIONS: RESULTS FROM THE ZEPHYR 2 STUDY. Ann Allergy Asthma Immunol 2021. [DOI: 10.1016/j.anai.2021.08.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Shin Y, Maeng S, Chung Y, Krumdick GK, Min S. Core-Multishell-Structured Digital-Gradient Cathode Materials with Enhanced Mechanical and Electrochemical Durability. Small 2021; 17:e2100040. [PMID: 33783108 DOI: 10.1002/smll.202100040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Revised: 02/21/2021] [Indexed: 06/12/2023]
Abstract
Ni-rich cathode materials provide high energy density, but their structural and surface instability limits their cyclability and thermal stability. As one of the approaches to mitigate this problem, cathode materials comprising Ni-rich high-capacity core wrapped in Mn-rich multiple shells are produced successfully. In contrast to the conventional batch-type process for concentration-gradient materials, a digital-gradient cascade coprecipitation process described here achieves the improvements in productivity and quality consistency needed to move toward large-scale manufacturing. The core-multishell cathode materials produced in this manner not only have longer cycle life and improved rate performance compared to homogeneous Ni-rich cathode materials having the same overall composition, but also show remarkably enhanced thermal stability and low impedance growth characteristics. In a novel attempt to determine the correlation between the mechanical properties of the core-multishell cathode particles and their electrochemical cyclabilities, their breaking force and elasticity were successfully measured using a statistical approach, which indicates that a cathode particle with stable surface composition as well as high breaking force has improved capacity retention and durability. These results guide the realization of long life and high thermal stability in Ni-rich cathode materials through heterogeneous particle engineering.
Collapse
Affiliation(s)
- Youngho Shin
- Materials Engineering Research Facility, Applied Materials Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Sangjin Maeng
- School of Mechanical Engineering, University of Wisconsin, Madison, WI, 53706, USA
| | - Youngmin Chung
- Materials Engineering Research Facility, Applied Materials Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Gregory K Krumdick
- Materials Engineering Research Facility, Applied Materials Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Sangkee Min
- School of Mechanical Engineering, University of Wisconsin, Madison, WI, 53706, USA
| |
Collapse
|
15
|
Davis G, Schladweiler K, Chung Y, Emmanuel B, Kreindler J, Katial R, Burton T, Blauer-Peterson C, Seare J, Peters A. P504 HEALTH CARE RESOURCE USE AND COST FOR PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS. Ann Allergy Asthma Immunol 2020. [DOI: 10.1016/j.anai.2020.08.162] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Yen J, Chung Y, Jen C. PD-0535: The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00557-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Peters A, Schladweiler K, Chung Y, Emmanuel B, Kreindler J, Katial R, Burton T, Blauer-Peterson C, Seare J, Davis G. P510 CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS: DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS BASED ON SURGERY STATUS. Ann Allergy Asthma Immunol 2020. [DOI: 10.1016/j.anai.2020.08.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
18
|
van der Kraaij GE, Balak DMW, Busard CI, van Cranenburgh OD, Chung Y, Driessen RJB, de Groot M, de Jong EMGJ, Kemperman PMJH, de Kort WJA, Karsch SA, Lamberts A, Lecluse LLA, van Lümig PPM, Menting SP, Prens EP, van den Reek JMPA, Seyger MMB, Thio HB, Veldkamp WR, Wakkee M, Nast A, Jacobs A, Rosumeck S, Spuls Chair PI. Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017. Br J Dermatol 2019; 180:31-42. [PMID: 30604536 PMCID: PMC6849803 DOI: 10.1111/bjd.17198] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/02/2018] [Indexed: 12/31/2022]
Abstract
Linked Comment: https://doi.org/10.1111/bjd.17390.
Collapse
Affiliation(s)
- G E van der Kraaij
- Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.,Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.,Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands
| | - D M W Balak
- University Medical Centre Utrecht, Utrecht, the Netherlands
| | - C I Busard
- Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.,Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - O D van Cranenburgh
- Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.,Dutch Skin Foundation, Nieuwegein, the Netherlands
| | - Y Chung
- Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands
| | - R J B Driessen
- Radboud University Medical Centre, Nijmegen, the Netherlands
| | - M de Groot
- Antonius Hospital, Sneek/Emmeloord, the Netherlands
| | - E M G J de Jong
- Radboud University Medical Centre, Nijmegen, the Netherlands.,Radboud University Nijmegen, the Netherlands
| | - P M J H Kemperman
- Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.,Waterlandziekenhuis, Purmerend, the Netherlands
| | | | - S A Karsch
- Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands
| | - A Lamberts
- Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.,University Medical Center Groningen, Groningen, the Netherlands
| | - L L A Lecluse
- Bergman Clinics and U-clinic, Amsterdam, the Netherlands
| | - P P M van Lümig
- Radboud University Medical Centre, Nijmegen, the Netherlands
| | - S P Menting
- Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - E P Prens
- Erasmus Medical Centre, Rotterdam, the Netherlands
| | | | - M M B Seyger
- Radboud University Medical Centre, Nijmegen, the Netherlands
| | - H B Thio
- Erasmus Medical Centre, Rotterdam, the Netherlands
| | - W R Veldkamp
- Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.,Radboud University Nijmegen, the Netherlands
| | - M Wakkee
- Erasmus Medical Centre, Rotterdam, the Netherlands
| | - A Nast
- Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
| | - A Jacobs
- Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
| | - S Rosumeck
- Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
| | - P I Spuls Chair
- Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.,Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| |
Collapse
|
19
|
Chung Y, Zeiger R, Zimmerman N, Sullivan P, Kreindler J, Tkacz J. D200 RELATIONSHIP BETWEEN SYSTEMIC CORTICOSTEROID USE, ASSOCIATED COMPLICATIONS, AND HEALTHCARE COSTS IN PATIENTS WITH PERSISTENT ASTHMA. Ann Allergy Asthma Immunol 2019. [DOI: 10.1016/j.anai.2019.08.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Sullivan P, Zeiger R, Kreindler J, Chung Y, Lucci M, Tkacz J. P225 PATTERNS OF SYSTEMIC CORTICOSTEROID EXPOSURE FOR PATIENTS WITH PERSISTENT ASTHMA: A US ADMINISTRATIVE CLAIMS ANALYSIS. Ann Allergy Asthma Immunol 2019. [DOI: 10.1016/j.anai.2019.08.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
21
|
Chung Y, van der Sande AAJ, de Roos KP, Bekkenk MW, de Haas ERM, Kelleners-Smeets NWJ, Kukutsch NA. Poor agreement between the automated risk assessment of a smartphone application for skin cancer detection and the rating by dermatologists. J Eur Acad Dermatol Venereol 2019; 34:274-278. [PMID: 31423673 PMCID: PMC7027514 DOI: 10.1111/jdv.15873] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Accepted: 07/19/2019] [Indexed: 12/03/2022]
Abstract
Background Several smartphone applications (app) with an automated risk assessment claim to be able to detect skin cancer at an early stage. Various studies that have evaluated these apps showed mainly poor performance. However, all studies were done in patients and lesions were mainly selected by a specialist. Objectives To investigate the performance of the automated risk assessment of an app by comparing its assessment to that of a dermatologist in lesions selected by the participants. Methods Participants of a National Skin Cancer Day were enrolled in a multicentre study. Skin lesions indicated by the participants were analysed by the automated risk assessment of the app prior to blinded rating by the dermatologist. The ratings of the automated risk assessment were compared to the assessment and diagnosis of the dermatologist. Due to the setting of the Skin Cancer Day, lesions were not verified by histopathology. Results We included 125 participants (199 lesions). The app was not able to analyse 90 cases (45%) of which nine BCC, four atypical naevi and one lentigo maligna. Thirty lesions (67%) with a high and 21 with a medium risk (70%) rating by the app were diagnosed as benign naevi or seborrhoeic keratoses. The interobserver agreement between the ratings of the automated risk assessment and the dermatologist was poor (weighted kappa = 0.02; 95% CI −0.08‐0.12; P = 0.74). Conclusions The rating of the automated risk assessment was poor. Further investigations about the diagnostic accuracy in real‐life situations are needed to provide consumers with reliable information about this healthcare application.
Collapse
Affiliation(s)
- Y Chung
- Dutch Society of Dermatology and Venereology, Utrecht, The Netherlands
| | | | - K P de Roos
- Dutch Society of Dermatology and Venereology, Utrecht, The Netherlands.,Dermapark, Uden, The Netherlands
| | - M W Bekkenk
- Department of Dermatology, Academic Medical Center and Vrije University Medical Center, Amsterdam, The Netherlands
| | - E R M de Haas
- Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - N W J Kelleners-Smeets
- Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands
| | - N A Kukutsch
- Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
| |
Collapse
|
22
|
Lee J, Chung Y, Kim S, Lee H, Kang J, Shon Y, Na D. A feasibility study with a novel, subcutaneous extracranial brain stimulator in a beagle model for non-invasive human neuromodulation. Brain Stimul 2019. [DOI: 10.1016/j.brs.2018.12.865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
23
|
Chung Y, Shin Y, Liu Y, Park JS, Margez CL, Greszler TA. Synergetic effect of carbon and AlF3 coatings on the lithium titanium oxide anode material for high power lithium-ion batteries. J Electroanal Chem (Lausanne) 2019. [DOI: 10.1016/j.jelechem.2019.02.037] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
24
|
Kim J, Chung Y, Lee J, Nam E, Kim S, Kim Y, Kim S. Comparison of Surgical Outcomes and 2-Year Disease Progression Free Survival Rate between Single-Port Access Staging Laparoscopy and Conventional Staging Laparoscopy in Uterine Cancer. J Minim Invasive Gynecol 2018. [DOI: 10.1016/j.jmig.2018.09.378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
25
|
Kim M, Chung Y, Hwang H, Namkung J, Han Y. Robot assisted laparoscopic myomectomy for submucosal myoma. Fertil Steril 2018. [DOI: 10.1016/j.fertnstert.2018.07.1137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Choi Y, Chung Y, Kim J, Hong M, Chae S, Hwang K, Yoon S. Association between polycystic ovary syndrome and the polymorphisms of aryl hydrocarbon receptor repressor, glutathione-s-transferase T1, and glutathione-S-transferase M1 genes. Fertil Steril 2018. [DOI: 10.1016/j.fertnstert.2018.07.357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Shi Y, Zhou H, Seymour ID, Britto S, Rana J, Wangoh LW, Huang Y, Yin Q, Reeves PJ, Zuba M, Chung Y, Omenya F, Chernova NA, Zhou G, Piper LFJ, Grey CP, Whittingham MS. Electrochemical Performance of Nanosized Disordered LiVOPO 4. ACS Omega 2018; 3:7310-7323. [PMID: 31458891 PMCID: PMC6644837 DOI: 10.1021/acsomega.8b00763] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Accepted: 06/19/2018] [Indexed: 06/10/2023]
Abstract
ε-LiVOPO4 is a promising multielectron cathode material for Li-ion batteries that can accommodate two electrons per vanadium, leading to higher energy densities. However, poor electronic conductivity and low lithium ion diffusivity currently result in low rate capability and poor cycle life. To enhance the electrochemical performance of ε-LiVOPO4, in this work, we optimized its solid-state synthesis route using in situ synchrotron X-ray diffraction and applied a combination of high-energy ball-milling with electronically and ionically conductive coatings aiming to improve bulk and surface Li diffusion. We show that high-energy ball-milling, while reducing the particle size also introduces structural disorder, as evidenced by 7Li and 31P NMR and X-ray absorption spectroscopy. We also show that a combination of electronically and ionically conductive coatings helps to utilize close to theoretical capacity for ε-LiVOPO4 at C/50 (1 C = 153 mA h g-1) and to enhance rate performance and capacity retention. The optimized ε-LiVOPO4/Li3VO4/acetylene black composite yields the high cycling capacity of 250 mA h g-1 at C/5 for over 70 cycles.
Collapse
Affiliation(s)
- Yong Shi
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Hui Zhou
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Ieuan D. Seymour
- Department
of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
| | - Sylvia Britto
- Department
of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
| | - Jatinkumar Rana
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Linda W. Wangoh
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Yiqing Huang
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Qiyue Yin
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Philip J. Reeves
- Department
of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
| | - Mateusz Zuba
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Youngmin Chung
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Fredrick Omenya
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Natasha A. Chernova
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Guangwen Zhou
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Louis F. J. Piper
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| | - Clare P. Grey
- Department
of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
| | - M. Stanley Whittingham
- Chemistry
and Materials Science and Engineering, NECCES, Department of Mechanical Engineering
and Materials Science and Engineering Program, and Department of Physics, Applied
Physics and Astronomy, Binghamton University, Binghamton, New York 13902, United States
| |
Collapse
|
28
|
Ruschel VC, Shibata S, Stolf SC, Chung Y, Baratieri LN, Heymann HO, Walter R. Eighteen-month Clinical Study of Universal Adhesives in Noncarious Cervical Lesions. Oper Dent 2018; 43:241-249. [PMID: 29676975 DOI: 10.2341/16-320-c] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE To evaluate the clinical performance of Scotchbond Universal (3M Oral Care) and Prime & Bond Elect (Dentsply Sirona) in the restoration of noncarious cervical lesions (NCCLs). METHODS AND MATERIALS This was a randomized controlled clinical trial involving 63 subjects. Two hundred and three NCCLs were restored using Scotchbond Universal and Prime & Bond Elect using both an etch-and-rinse and a self-etch technique. Lesions were notch-shaped NCCLs, and the restorations were placed without any mechanical retention. Restorations were finished immediately after placement and scored with regard to retention, marginal discoloration, marginal adaptation, and secondary caries. Similar assessment of the restorations was performed 18 months after placement. Logistic regression was performed for each outcome separately with a compound symmetric variance-covariance structure assumed to consider a correlation of restorations within subjects. All analyses were conducted using SAS version 9.4 (SAS Inc). RESULTS One hundred and fifty-eight teeth (77.8% of the restorations placed) in 46 subjects (73% of subjects enrolled) were available for the 18-month follow-up. A statistically significant difference was reached only for the comparison Scotchbond Universal/self-etch (SU_SE) and Prime & Bond Elect/etch-and-rinse (PBE_E&R) groups ( p=0.01), where a restoration with SU_SE was 66% less likely to maintain a score of Alpha for marginal discoloration than a restoration performed with PBE_E&R. CONCLUSIONS Scotchbond Universal and Prime & Bond Elect presented acceptable clinical performance after 18 months of clinical service. However, Scotchbond Universal, when applied with a self-etch approach, did demonstrate a relatively high level of marginal discoloration when compared to the other groups.
Collapse
|
29
|
Ryu K, Kim Y, Chung Y, Chey Y, Kang Y. C-43Relationship Between Vocabulary And Verbal / Visual Memory For Baseline Use Of Memory Impairment. Arch Clin Neuropsychol 2017. [DOI: 10.1093/arclin/acx076.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Chung Y, Choi Y. TRANSCRIPTIONAL PROFILING OF HUMAN FEMORAL MESENCHYMAL STEM CELLS IN OSTEOPOROSIS AND ADIPOGENESIS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.2043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Y. Chung
- Endocrinology, Ajou University School of Medicine, Suwon, Korea (the Republic of)
| | - Y. Choi
- Endocrinology, Ajou University School of Medicine, Suwon, Korea (the Republic of)
| |
Collapse
|
31
|
Kim C, Nam D, Kong D, Kang S, Jang J, Kim J, Lim Y, Koh Y, Chung Y, Kim J. OS09.7 Phase III radomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox036.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Chung Y, Cecere R, Mongrain R, Azar T. A NOVEL DUAL-ANGLE BLADE, CORELESS VENTRICULAR ASSIST DEVICE. Can J Cardiol 2016. [DOI: 10.1016/j.cjca.2016.07.269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
33
|
Han HR, Lee JE, Kim K, Chung Y, Kim MT, Robinson C, Lee M. Healthcare utilization among North Korean refugees in South Korea: a mixed methods study. Public Health 2016; 142:116-120. [PMID: 27592505 DOI: 10.1016/j.puhe.2016.07.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2015] [Revised: 07/23/2016] [Accepted: 07/29/2016] [Indexed: 11/16/2022]
Affiliation(s)
- H R Han
- The Johns Hopkins University School of Nursing, Baltimore, MD, USA.
| | - J E Lee
- Catholic University of Korea College of Nursing, Seoul, Republic of Korea
| | - K Kim
- The Johns Hopkins University School of Nursing, Baltimore, MD, USA
| | - Y Chung
- The Johns Hopkins University School of Nursing, Baltimore, MD, USA
| | - M T Kim
- University of Texas at Austin School of Nursing, Austin, TX, USA
| | - C Robinson
- The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
| | - M Lee
- Yonsei University School of Public Health, Seoul, Republic of Korea
| |
Collapse
|
34
|
Huang Y, Lin YC, Jenkins DM, Chernova NA, Chung Y, Radhakrishnan B, Chu IH, Fang J, Wang Q, Omenya F, Ong SP, Whittingham MS. Thermal Stability and Reactivity of Cathode Materials for Li-Ion Batteries. ACS Appl Mater Interfaces 2016; 8:7013-7021. [PMID: 26915096 DOI: 10.1021/acsami.5b12081] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The thermal stability of electrochemically delithiated Li0.1Ni0.8Co0.15Al0.05O2 (NCA), FePO4 (FP), Mn0.8Fe0.2PO4 (MFP), hydrothermally synthesized VOPO4, LiVOPO4, and electrochemically lithiated Li2VOPO4 is investigated by differential scanning calorimetry (DSC) and thermogravimetric analysis, coupled with mass spectrometry (TGA-MS). The thermal stability of the delithiated materials is found to be in the order of NCA < VOPO4 < MFP < FP. Unlike the layered oxides and MFP, VOPO4 does not evolve O2 on heating. Thus, VOPO4 is less likely to cause a thermal run-away phenomenon in batteries at elevated temperature and so is inherently safer. The lithiated materials LiVOPO4, Li2VOPO4, and LiNi0.8Co0.15Al0.05O2 are found to be stable in the presence of electrolyte, but sealed-capsule high-pressure experiments show a phase transformation of VOPO4 → HVOPO4 → H2VOPO4 when VOPO4 reacts with electrolyte (1 M LiPF6 in EC/DMC = 1:1) between 200 and 300 °C. Using first-principles calculations, we confirm that the charged VOPO4 cathode is indeed predicted to be marginally less stable than FP but significantly more stable than NCA in the absence of electrolyte. An analysis of the reaction equilibria between VOPO4 and EC using a multicomponent phase diagram approach yields products and reaction enthalpies that are highly consistent with the experiment results.
Collapse
Affiliation(s)
- Yiqing Huang
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Yuh-Chieh Lin
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - David M Jenkins
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Natasha A Chernova
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Youngmin Chung
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Balachandran Radhakrishnan
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Iek-Heng Chu
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Jin Fang
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Qi Wang
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Fredrick Omenya
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Shyue Ping Ong
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| | - M Stanley Whittingham
- Chemistry and Materials and ‡Department of Geology, Binghamton University , Binghamton, New York 13902-6000, United States
- Materials Science and Engineering Program and ∥Department of NanoEngineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States
| |
Collapse
|
35
|
Sung-Woo C, Kim Y, Kim Y, Chung Y. The clinical efficacy of N-Methyl D-Aspartate receptor antagonist for parkinson's disease dementia: brain perfusion spect study. J Neurol Sci 2015. [DOI: 10.1016/j.jns.2015.08.444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
36
|
Kim J, Park C, Kauweloa K, Chung Y, Han Y, Ju S. TU-CD-207-05: A Novel Digital Tomosynthesis System Using Orthogonal Scanning Technique: A Feasibility Study. Med Phys 2015. [DOI: 10.1118/1.4925624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
37
|
Chung Y, Shin J, Yu J, Park W, Choi D, Huh S, Han Y, Kim J. SU-E-T-292: Dosimetric Advantage of Prone Breast Radiotherapy for Korean Left-Sided Breast Cancer Patients. Med Phys 2015. [DOI: 10.1118/1.4924654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
38
|
Cheng S, Chung Y, Liu M, Tsou J, Chen S, Kuo T, Lin N. The investigation of effects of upper extremity exercise program on hand functions in patients on maintenance hemodialysis. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
39
|
Lee J, Hur E, Jung S, Choi Y, Goo B, Moon J, Choi E, Chung Y, Kim Y. 161 CYTOGENETIC CHARACTERIZATION OF AZACITIDINE-RESISTANT CELL LINE (MOLM/AZA-1) ESTABLISHED FROM AML/MDS CELL LINE (MOLM-13). Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30162-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Kim C, Lee N, Yoon W, Chung Y, Lee N. PO-0796: Volumetric analysis of MRI response in meninigiomas treated with 3-dimensional conformal radiation therapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40788-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
41
|
Chung Y, Lee J, Oh S, Park D, Chang HH, Kim S. Automatic Detection of Cow's Oestrus in Audio Surveillance System. Asian-Australas J Anim Sci 2014; 26:1030-7. [PMID: 25049882 PMCID: PMC4093488 DOI: 10.5713/ajas.2012.12628] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/09/2012] [Revised: 03/03/2013] [Accepted: 01/29/2013] [Indexed: 12/21/2022]
Abstract
Early detection of anomalies is an important issue in the management of group-housed livestock. In particular, failure to detect oestrus in a timely and accurate way can become a limiting factor in achieving efficient reproductive performance. Although a rich variety of methods has been introduced for the detection of oestrus, a more accurate and practical method is still required. In this paper, we propose an efficient data mining solution for the detection of oestrus, using the sound data of Korean native cows (Bos taurus coreanea). In this method, we extracted the mel frequency cepstrum coefficients from sound data with a feature dimension reduction, and use the support vector data description as an early anomaly detector. Our experimental results show that this method can be used to detect oestrus both economically (even a cheap microphone) and accurately (over 94% accuracy), either as a standalone solution or to complement known methods.
Collapse
Affiliation(s)
- Y Chung
- Department of Computer and Information Science, College of Science and Technology, Korea University, Sejong 339-700, Korea
| | - J Lee
- Department of Computer and Information Science, College of Science and Technology, Korea University, Sejong 339-700, Korea
| | - S Oh
- Department of Computer and Information Science, College of Science and Technology, Korea University, Sejong 339-700, Korea
| | - D Park
- Department of Computer and Information Science, College of Science and Technology, Korea University, Sejong 339-700, Korea
| | - H H Chang
- Department of Computer and Information Science, College of Science and Technology, Korea University, Sejong 339-700, Korea
| | - S Kim
- Department of Computer and Information Science, College of Science and Technology, Korea University, Sejong 339-700, Korea
| |
Collapse
|
42
|
Wang C, Nguyen G, Chung Y, Cabrera F, Shin R, Lipkin M, Yoshizumi T. SU-C-18C-04: Evaluation of Effective Dose During Ureteroscopy for Obese and Non-Obese Patients. Med Phys 2014. [DOI: 10.1118/1.4887838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
43
|
Chung Y, Fu E. Cyclosporine A up-regulates Sonic hedgehog in gingiva: role of the up-regulation on gingival cell proliferation. J Periodontal Res 2014; 49:810-6. [PMID: 24823913 DOI: 10.1111/jre.12168] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/21/2013] [Indexed: 11/28/2022]
Abstract
BACKGROUND AND OBJECTIVE Sonic hedgehog protein (SHH) is a mitogen that stimulates cell proliferation. Cyclosporine A enhances the proliferation of gingival cells; however, the relationships of SHH to cyclosporine A or to cyclosporine A-enhanced gingival cell proliferation have not been described. MATERIAL AND METHODS Here, we investigated SHH expression in gingiva in vitro and in vivo after cyclosporine A treatment and tested the effect of SHH inhibition on cyclosporine A-enhanced gingival fibroblast proliferation in vitro. RESULTS In human gingival fibroblasts, cyclosporine A treatment increased the expression of SHH transcripts and SHH protein, and stimulated cell proliferation; the addition of cyclopamine, an SHH signaling inhibitor, suppressed cyclosporine A-enhanced cell proliferation. Up-regulated expression of SHH and up-regulation of proliferating cell nuclear antigen transcripts and protein were observed in the edentulous gingiva of cyclosporine A-treated rats. CONCLUSION Cyclosporine A up-regulates gingival SHH expression in vitro and in vivo, and the inhibition of the SHH pathway counteracts the stimulatory effect of cyclosporine A on gingival fibroblast proliferation. Therefore, we suggest that SHH mediates a novel molecular mechanism for cyclosporine A-induced gingival complications.
Collapse
Affiliation(s)
- Y Chung
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, China; Department of Periodontology, School of Dentistry, National Defense Medical Center and Tri-Service General Hospital, Taipei, Taiwan, China
| | | |
Collapse
|
44
|
Chung Y, Yoon HI, Ha JS, Kim S, Lee IJ. A Feasibility Study of a Tilted Head Position in Helical Tomotherapy for Fractionated Stereotactic Radiotherapy of Intracranial Malignancies. Technol Cancer Res Treat 2014:tcrt.2012.50042. [PMID: 24645743 DOI: 10.7785/tcrt.2012.500420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/28/2024] Open
Abstract
Herein, we evaluated the feasibility of placing patients in a tilted head position as part of routine clinical practice for fractionated stereotactic radiotherapy (FSRT) of intracranial tumors using helical tomotherapy (HT), by assessing its dosimetric benefit and setup accuracy. We reviewed treatment plans of four cases that were to receive FSRT for brain lesions in normal and head-tilted positions. These patients underwent two computed tomography (CT) scans: first in the normal supine position and then in the supine position with the head tilted at a 458 angle. Two separate HT plans for each position were generated in these four patients, using the same planning parameters. Plans were compared for target conformity and dose homogeneity. Maximum and average doses to critical organs, including normal brain, brain stem, optic chiasm, optic nerves, and the eyes, were considered. To evaluate setup accuracy, patient movement during treatment was assessed by post-treatment megavoltage CT scans. Both HT plans achieved similar conformal and homogeneous dose coverage to the target. Head-tilted HT delivered lower average and maximum doses to critical organs in the cases where the tumor was located on the same plane with critical organs, particularly when they were not directly attached. Placement in the head-tilted position without a mouthpiece allowed for increased patient movement during treatment, while use of a mouthpiece reduced patient movement to even less than that observed for normal setup in the supine position. This pilot study showed that placement in a tilted head position for FSRT of intracranial tumors using HT may be of clinical use, but depends on the tumor location.
Collapse
Affiliation(s)
- Y Chung
- Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea.
| | | | | | | | | |
Collapse
|
45
|
Seo M, Hong C, Lee SY, Choi HK, Kim N, Chung Y, Umansky V, Mahalu D. Multi-valued logic gates based on ballistic transport in quantum point contacts. Sci Rep 2014; 4:3806. [PMID: 24448272 PMCID: PMC3897954 DOI: 10.1038/srep03806] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2013] [Accepted: 12/23/2013] [Indexed: 11/22/2022] Open
Abstract
Multi-valued logic gates, which can handle quaternary numbers as inputs, are developed by exploiting the ballistic transport properties of quantum point contacts in series. The principle of a logic gate that finds the minimum of two quaternary number inputs is demonstrated. The device is scalable to allow multiple inputs, which makes it possible to find the minimum of multiple inputs in a single gate operation. Also, the principle of a half-adder for quaternary number inputs is demonstrated. First, an adder that adds up two quaternary numbers and outputs the sum of inputs is demonstrated. Second, a device to express the sum of the adder into two quaternary digits [Carry (first digit) and Sum (second digit)] is demonstrated. All the logic gates presented in this paper can in principle be extended to allow decimal number inputs with high quality QPCs.
Collapse
Affiliation(s)
- M Seo
- Department of Physics, Pusan National University, Busan, 609-735, Republic of Korea
| | - C Hong
- Department of Physics, Pusan National University, Busan, 609-735, Republic of Korea
| | - S-Y Lee
- 1] Department of Physics, Pusan National University, Busan, 609-735, Republic of Korea [2] School of Electronics Engineering, Kyungpook National University, Daegu, 702-701, Republic of Korea
| | - H K Choi
- Department of Condensed Matter Physics, Weizmann Institute of Science, Rehovot, 76100, Israel
| | - N Kim
- Korea Research Institute of Standard and Science, Daejeon, 306-600, Republic of Korea
| | - Y Chung
- Department of Physics, Pusan National University, Busan, 609-735, Republic of Korea
| | - V Umansky
- Department of Condensed Matter Physics, Weizmann Institute of Science, Rehovot, 76100, Israel
| | - D Mahalu
- Department of Condensed Matter Physics, Weizmann Institute of Science, Rehovot, 76100, Israel
| |
Collapse
|
46
|
Lee J, Suh C, Lee H, Yoon J, Park K, Chung Y, Choi W, Kim J. EP-1472: Reducing effectiveness of hair loss by additional lead block for electron treatment of eyelid lesion patients. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31590-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
47
|
Lee H, Yoon J, Lee J, Park K, Chung Y, Choi W. EP-1724: Fast scan and low dose megavoltage CT reconstruction via a compressed censing with prior image constraints in IGRT. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31842-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Song J, Chung Y, Kim Y, Lee J, Lee N, Bae H. Circulating endothelial progenitor cells in gynecologic cancer. Gynecol Oncol 2013. [DOI: 10.1016/j.ygyno.2013.04.449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
49
|
Seo M, Choi HK, Lee SY, Kim N, Chung Y, Sim HS, Umansky V, Mahalu D. Charge frustration in a triangular triple quantum dot. Phys Rev Lett 2013; 110:046803. [PMID: 25166188 DOI: 10.1103/physrevlett.110.046803] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2012] [Indexed: 06/03/2023]
Abstract
We experimentally investigate the charge (isospin) frustration induced by a geometrical symmetry in a triangular triple quantum dot. We observe the ground-state charge configurations of sixfold degeneracy, the manifestation of the frustration. The frustration results in omnidirectional charge transport, and it is accompanied by nearby nontrivial triple degenerate states in the charge stability diagram. The findings agree with a capacitive interaction model. We also observe unusual transport by the frustration, which might be related to elastic cotunneling and the interference of trajectories through the dot. This work demonstrates a unique way of studying geometrical frustration in a controllable way.
Collapse
Affiliation(s)
- M Seo
- Department of Physics, Pusan National University, Busan 609-735, Republic of Korea
| | - H K Choi
- Braun Center for Submicron Research, Department of Condensed Matter Physics, Weizmann Institute of Science, Rehovot 76100, Israel
| | - S-Y Lee
- Department of Physics, Pusan National University, Busan 609-735, Republic of Korea
| | - N Kim
- Korea Research Institute of Standard and Science, Daejeon 306-600, Republic of Korea
| | - Y Chung
- Department of Physics, Pusan National University, Busan 609-735, Republic of Korea
| | - H-S Sim
- Department of Physics, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea
| | - V Umansky
- Braun Center for Submicron Research, Department of Condensed Matter Physics, Weizmann Institute of Science, Rehovot 76100, Israel
| | - D Mahalu
- Braun Center for Submicron Research, Department of Condensed Matter Physics, Weizmann Institute of Science, Rehovot 76100, Israel
| |
Collapse
|
50
|
Chung Y, Kelsey C, Das S. The Impact of Anatomical Changes During the Course of Intensity Modulated Radiation Therapy (IMRT) for Lung Cancer. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|